Efalizumab withdrawal/etanercept: Erythrodermic flare of plaque psoriasis: 3 case reports

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1220, 2008-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efalizumab: Inflammatory psoriasis flare: 6 case reports

Reactions Weekly, Vol. 1, Iss. 1270, 2009-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Etanercept, efalizumab repair QOL in chronic plaque psoriasis

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Etanercept, efalizumab repair QOL in chronic plaque psoriasis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 463, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Efalizumab withdrawal: Psoriatic arthritis in patients with psoriasis: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1154, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Etanercept/infliximab: Worsening of plaque psoriasis, thrombocytopenia, congestive heart failure and sepsis: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1189, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite